Immunologic response of man to group B meningococcal polysaccharide vaccines.
D000917:Antibody Formation / Q000187:drug effects; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D001666:Binding Sites, Antibody; D001789:Blood Group Antigens; D002845:Chromatography; D004890:Erythema / Q000139:chemically induced; D005455:Fluorescent Antibody Technique; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006801:Humans; D007104:Immune Adherence Reaction; D007252:Influenza Vaccines / Q000494:pharmacology; D007279:Injections, Subcutaneous; D007519:Isoantigens; D007841:Latex Fixation Tests; D008297:Male; D008970:Molecular Weight; D009345:Neisseria meningitidis / Q000276:immunology; D009438:Neuraminic Acids / Q000032:analysis; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D001428:Bacterial Vaccines; D001789:Blood Group Antigens; D007252:Influenza Vaccines; D007519:Isoantigens; D009438:Neuraminic Acids; D011135:Polysaccharides, Bacterial